Executive function, survival, and hospitalization in chronic obstructive pulmonary disease

A longitudinal analysis of the national emphysema treatment trial (NETT)

James W. Dodd, Paul Novotny, Frank C. Sciurba, Roberto P Benzo

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Rationale: Cognitive dysfunction has been demonstrated in chronic obstructive pulmonary disease (COPD), but studies are limited to cross-sectional analyses or incompletely characterized populations. Objectives: We examined longitudinal changes in sensitive measures of executive function in a well-characterized population of patients with severe COPD. Methods: This study was performed on patients enrolled in the National Emphysema Treatment Trial. To assess executive function, we analyzed trail making (TM) A and B times at enrollment in the trial (2,128 patients), and at 12 (731 patients) and 24 months (593 patients) after enrollment, adjusted for surgery, marriage status, age, education, income, depression, PaO2, PaCO2, and smoking. Associations with survival and hospitalizations were examined using Cox regression and linear regression models. Measurements and Main Results: The average age of the patients was 66.4 years, and the averageFEV1 was 23.9% predicted. At the time of enrolment, 38% had executive dysfunction. Compared with those who did not, these patients were older, less educated, had higher oxygen use, higher PaCO2, worse quality of life as measured by the St. George's Respiratory Quotient, reduced well-being, and lower social function. There was no significant change over 2 years in TM A or B times after adjustment for covariables. Changes in TM B times were modestly associated with survival, but changes in TM B2A times were not. Changes in TM scores were not associated with frequency of hospitalization. Lung function, PaO2, smoking, survival, and hospitalizations were not significantly different in those with executive dysfunction. Conclusions: In this large population of patients with severe emphysema and heavy cigarette smoking exposure, there was no significant decline over 2 years in cognitive executive function as measured by TM tests. There was no association between executive function impairment and frequency of hospitalization, and there was a possible modest association with survival. It is plausible that cerebrovascular comorbidities explain previously described cognitive pathology in COPD.

Original languageEnglish (US)
Pages (from-to)1473-1481
Number of pages9
JournalAnnals of the American Thoracic Society
Volume12
Issue number10
DOIs
StatePublished - Oct 1 2015

Fingerprint

Executive Function
Emphysema
Chronic Obstructive Pulmonary Disease
Hospitalization
Survival
Smoking
Therapeutics
Linear Models
Trail Making Test
Population
Marriage
Cognition
Comorbidity
Cross-Sectional Studies
Quality of Life
Depression
Pathology
Oxygen
Education
Lung

Keywords

  • Chronic obstructive pulmonary disease
  • Cognition
  • Executive function
  • Hospitalization
  • Survival

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Executive function, survival, and hospitalization in chronic obstructive pulmonary disease : A longitudinal analysis of the national emphysema treatment trial (NETT). / Dodd, James W.; Novotny, Paul; Sciurba, Frank C.; Benzo, Roberto P.

In: Annals of the American Thoracic Society, Vol. 12, No. 10, 01.10.2015, p. 1473-1481.

Research output: Contribution to journalArticle

@article{a800421155ae4705828ea8c12fe8def2,
title = "Executive function, survival, and hospitalization in chronic obstructive pulmonary disease: A longitudinal analysis of the national emphysema treatment trial (NETT)",
abstract = "Rationale: Cognitive dysfunction has been demonstrated in chronic obstructive pulmonary disease (COPD), but studies are limited to cross-sectional analyses or incompletely characterized populations. Objectives: We examined longitudinal changes in sensitive measures of executive function in a well-characterized population of patients with severe COPD. Methods: This study was performed on patients enrolled in the National Emphysema Treatment Trial. To assess executive function, we analyzed trail making (TM) A and B times at enrollment in the trial (2,128 patients), and at 12 (731 patients) and 24 months (593 patients) after enrollment, adjusted for surgery, marriage status, age, education, income, depression, PaO2, PaCO2, and smoking. Associations with survival and hospitalizations were examined using Cox regression and linear regression models. Measurements and Main Results: The average age of the patients was 66.4 years, and the averageFEV1 was 23.9{\%} predicted. At the time of enrolment, 38{\%} had executive dysfunction. Compared with those who did not, these patients were older, less educated, had higher oxygen use, higher PaCO2, worse quality of life as measured by the St. George's Respiratory Quotient, reduced well-being, and lower social function. There was no significant change over 2 years in TM A or B times after adjustment for covariables. Changes in TM B times were modestly associated with survival, but changes in TM B2A times were not. Changes in TM scores were not associated with frequency of hospitalization. Lung function, PaO2, smoking, survival, and hospitalizations were not significantly different in those with executive dysfunction. Conclusions: In this large population of patients with severe emphysema and heavy cigarette smoking exposure, there was no significant decline over 2 years in cognitive executive function as measured by TM tests. There was no association between executive function impairment and frequency of hospitalization, and there was a possible modest association with survival. It is plausible that cerebrovascular comorbidities explain previously described cognitive pathology in COPD.",
keywords = "Chronic obstructive pulmonary disease, Cognition, Executive function, Hospitalization, Survival",
author = "Dodd, {James W.} and Paul Novotny and Sciurba, {Frank C.} and Benzo, {Roberto P}",
year = "2015",
month = "10",
day = "1",
doi = "10.1513/AnnalsATS.201506-373OC",
language = "English (US)",
volume = "12",
pages = "1473--1481",
journal = "Annals of the American Thoracic Society",
issn = "2325-6621",
publisher = "American Thoracic Society",
number = "10",

}

TY - JOUR

T1 - Executive function, survival, and hospitalization in chronic obstructive pulmonary disease

T2 - A longitudinal analysis of the national emphysema treatment trial (NETT)

AU - Dodd, James W.

AU - Novotny, Paul

AU - Sciurba, Frank C.

AU - Benzo, Roberto P

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Rationale: Cognitive dysfunction has been demonstrated in chronic obstructive pulmonary disease (COPD), but studies are limited to cross-sectional analyses or incompletely characterized populations. Objectives: We examined longitudinal changes in sensitive measures of executive function in a well-characterized population of patients with severe COPD. Methods: This study was performed on patients enrolled in the National Emphysema Treatment Trial. To assess executive function, we analyzed trail making (TM) A and B times at enrollment in the trial (2,128 patients), and at 12 (731 patients) and 24 months (593 patients) after enrollment, adjusted for surgery, marriage status, age, education, income, depression, PaO2, PaCO2, and smoking. Associations with survival and hospitalizations were examined using Cox regression and linear regression models. Measurements and Main Results: The average age of the patients was 66.4 years, and the averageFEV1 was 23.9% predicted. At the time of enrolment, 38% had executive dysfunction. Compared with those who did not, these patients were older, less educated, had higher oxygen use, higher PaCO2, worse quality of life as measured by the St. George's Respiratory Quotient, reduced well-being, and lower social function. There was no significant change over 2 years in TM A or B times after adjustment for covariables. Changes in TM B times were modestly associated with survival, but changes in TM B2A times were not. Changes in TM scores were not associated with frequency of hospitalization. Lung function, PaO2, smoking, survival, and hospitalizations were not significantly different in those with executive dysfunction. Conclusions: In this large population of patients with severe emphysema and heavy cigarette smoking exposure, there was no significant decline over 2 years in cognitive executive function as measured by TM tests. There was no association between executive function impairment and frequency of hospitalization, and there was a possible modest association with survival. It is plausible that cerebrovascular comorbidities explain previously described cognitive pathology in COPD.

AB - Rationale: Cognitive dysfunction has been demonstrated in chronic obstructive pulmonary disease (COPD), but studies are limited to cross-sectional analyses or incompletely characterized populations. Objectives: We examined longitudinal changes in sensitive measures of executive function in a well-characterized population of patients with severe COPD. Methods: This study was performed on patients enrolled in the National Emphysema Treatment Trial. To assess executive function, we analyzed trail making (TM) A and B times at enrollment in the trial (2,128 patients), and at 12 (731 patients) and 24 months (593 patients) after enrollment, adjusted for surgery, marriage status, age, education, income, depression, PaO2, PaCO2, and smoking. Associations with survival and hospitalizations were examined using Cox regression and linear regression models. Measurements and Main Results: The average age of the patients was 66.4 years, and the averageFEV1 was 23.9% predicted. At the time of enrolment, 38% had executive dysfunction. Compared with those who did not, these patients were older, less educated, had higher oxygen use, higher PaCO2, worse quality of life as measured by the St. George's Respiratory Quotient, reduced well-being, and lower social function. There was no significant change over 2 years in TM A or B times after adjustment for covariables. Changes in TM B times were modestly associated with survival, but changes in TM B2A times were not. Changes in TM scores were not associated with frequency of hospitalization. Lung function, PaO2, smoking, survival, and hospitalizations were not significantly different in those with executive dysfunction. Conclusions: In this large population of patients with severe emphysema and heavy cigarette smoking exposure, there was no significant decline over 2 years in cognitive executive function as measured by TM tests. There was no association between executive function impairment and frequency of hospitalization, and there was a possible modest association with survival. It is plausible that cerebrovascular comorbidities explain previously described cognitive pathology in COPD.

KW - Chronic obstructive pulmonary disease

KW - Cognition

KW - Executive function

KW - Hospitalization

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=84943591156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943591156&partnerID=8YFLogxK

U2 - 10.1513/AnnalsATS.201506-373OC

DO - 10.1513/AnnalsATS.201506-373OC

M3 - Article

VL - 12

SP - 1473

EP - 1481

JO - Annals of the American Thoracic Society

JF - Annals of the American Thoracic Society

SN - 2325-6621

IS - 10

ER -